← Back to Search

Immediate intervention start: active exercise for Parkinson's Disease (EBEPD Trial)

N/A

Recruiting

Led By Vesna Sossi

Research Sponsored by Pacific Parkinson's Research Centre

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up six months

Awards & highlights

EBEPD Trial Summary

This trialundefined

Who is the study for?

This trial is for people with Parkinson's Disease who can lay still for up to 90 minutes and are medically cleared to exercise. They shouldn't have severe claustrophobia, metal implants, significant cardiovascular or respiratory disease, other neurological or psychiatric disorders, recent surgeries or tattoos, substance use problems, be pregnant/breastfeeding, weigh over 158kg (347 lbs), or have a history of cancer within the last 5 years.Check my eligibility

What is being tested?

The study investigates if active and passive exercises affect brain energy usage in Parkinson's patients by comparing before-and-after brain scans using fMRI and PET. Healthy volunteers will also be scanned for comparison. Participants must currently exercise less than two hours per week.See study design

What are the potential side effects?

While not drug-related, side effects may include typical risks associated with physical exercise such as muscle soreness or strain. The imaging procedures might cause discomfort due to lying still in a confined space during scanning.

EBEPD Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ six months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~six months

This trial's timeline: 3 weeks for screening, Varies for treatment, and six months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

PET/MRI

Other outcome measures

Clinical measure: cognitive function

Clinical measure: motor function

EBEPD Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Immediate intervention start: active exerciseActive Control1 Intervention

Immediately starts the six month intervention of active exercise following the baseline scan.

Group II: Delayed intervention start: passive exercisePlacebo Group2 Interventions

Starts the six month intervention of active exercise six months after the baseline scan. During the six month delay, participants in this arm undergo passive exercise.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Pacific Parkinson's Research CentreLead Sponsor

6 Previous Clinical Trials

115 Total Patients Enrolled

Natural Sciences and Engineering Research Council, CanadaOTHER

57 Previous Clinical Trials

3,049 Total Patients Enrolled

Vesna SossiPrincipal InvestigatorUniversity of British Columbia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many subjects have registered for participation in this research project?

"Indeed, clinicaltrials.gov has information suggesting that this trial began recruiting patients on January 26th 2021 and is still open today with the last update occurring on February 1st 2022. This medical study seeks to enroll 40 individuals across a single site."

Answered by AI

Is my eligibility to join this experiment confirmed?

"We are searching for 40 individuals between the ages of 40 and 80 who have been diagnosed with Parkinson's disease. Additionally, eligible participants must not exceed 120 minutes of physical activity per week (as defined by our PD non-exercisers criteria)."

Answered by AI

Is this research experiment actively seeking participants?

"According to clinicaltrials.gov, this health research is currently seeking participants. The original trial posting was on January 26th 2021 and the information was last amended on February 1st 2022."

Answered by AI